2004•Matrix BiologyOpen access

Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice

Despina Sitara, Mohammed S. Razzaque, Martina Hesse, Subbiah Yoganathan, Takashi Taguchi, Reinhold G. Erben, Harald J APw-ppner, Beate Lanske

Open full text 544 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 544 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Fibroblast growth factor 23, Hypophosphatemia, PHEX, Hyperphosphatemia, Endocrinology, Internal medicine, Fibroblast growth factor, Osteomalacia

Back to paper search Browse research topics Original source

Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice — Research Paper | ScholarLens